Clover Health (CLOV) Gets New ‘Buy’ Call, Higher PT, Climbs 8.5%

insidermonkey.com · 2026-09-11

Clover Health Investments (NASDAQ:CLOV) grew its share price by 8.53 percent on Thursday to finish at $4.71 apiece, as investors took heart from Deutsche Bank’s optimistic rating for its stock.

TickrTrends take: Clover Health received a new buy rating with an increased price target, contributing to an 8 percent gain in the stock. With TickrTrends currently awaiting full valuation on the Healthcare company, investors focused on fundamental value should monitor whether this analyst upgrade reflects improved business metrics or represents a shift in market sentiment that may not yet be supported by comprehensive valuation analysis. The timing of such upgrades relative to CLOV's actual earnings performance and financial positioning will be important for determining whether the stock movement aligns with underlying value creation in the healthcare sector.

Read the full story at insidermonkey.com →